Cardiovascular diseases may play a negative role in the prognosis of amyotrophic lateral sclerosis

J Mandrioli, L Ferri, A Fasano, E Zucchi, N Fini, C Moglia, C Lunetta, K Marinou, N Ticozzi, G Drago Ferrante, C Scialo, G Sorarù, F Trojsi, A Conte, Y M Falzone, R Tortelli, M Russo, V A Sansone, G Mora, V SilaniP Volanti, C Caponnetto, G Querin, M R Monsurrò, M Sabatelli, A Chiò, N Riva, G Logroscino, S Messina, A Calvo

Research output: Contribution to journalArticle

Abstract

BACKGROUND AND PURPOSE: Only a few studies have considered the role of comorbidities in the prognosis of amyotrophic lateral sclerosis (ALS) and have provided conflicting results.

METHODS: Our multicentre, retrospective study included patients diagnosed from 1 January 2009 to 31 December 2013 in 13 referral centres for ALS located in 10 Italian regions. Neurologists at these centres collected a detailed phenotypic profile and follow-up data until death in an electronic database. Comorbidities at diagnosis were recorded by main categories and single medical diagnosis, with the aim of investigating their role in ALS prognosis.

RESULTS: A total of 2354 incident cases were collected, with a median survival time from onset to death/tracheostomy of 43 months. According to univariate analysis, together with well-known clinical prognostic factors (age at onset, diagnostic delay, site of onset, phenotype, Revised El Escorial Criteria and body mass index at diagnosis), the presence of dementia, hypertension, heart disease, chronic obstructive pulmonary disease, haematological and psychiatric diseases was associated with worse survival. In multivariate analysis, age at onset, diagnostic delay, phenotypes, body mass index at diagnosis, Revised El Escorial Criteria, dementia, hypertension, heart diseases (atrial fibrillation and heart failure) and haematological diseases (disorders of thrombosis and haemostasis) were independent prognostic factors of survival in ALS.

CONCLUSIONS: Our large, multicentre study demonstrated that, together with the known clinical factors that are known to be prognostic for ALS survival, hypertension and heart diseases (i.e. atrial fibrillation and heart failure) as well as haematological diseases are independently associated with a shorter survival. Our findings suggest some mechanisms that are possibly involved in disease progression, giving new interesting clues that may be of value for clinical practice and ALS comorbidity management.

Original languageEnglish
Pages (from-to)861-868
Number of pages8
JournalEuropean Journal of Neurology
Volume25
Issue number6
DOIs
Publication statusPublished - Jun 2018

Fingerprint

Amyotrophic Lateral Sclerosis
Cardiovascular Diseases
Heart Diseases
Hematologic Diseases
Survival
Comorbidity
Hypertension
Age of Onset
Atrial Fibrillation
Multicenter Studies
Dementia
Body Mass Index
Heart Failure
Phenotype
Tracheostomy
Hemostasis
Chronic Obstructive Pulmonary Disease
Psychiatry
Disease Progression
Thrombosis

Cite this

Mandrioli, J., Ferri, L., Fasano, A., Zucchi, E., Fini, N., Moglia, C., ... Calvo, A. (2018). Cardiovascular diseases may play a negative role in the prognosis of amyotrophic lateral sclerosis. European Journal of Neurology, 25(6), 861-868. https://doi.org/10.1111/ene.13620

Cardiovascular diseases may play a negative role in the prognosis of amyotrophic lateral sclerosis. / Mandrioli, J; Ferri, L; Fasano, A; Zucchi, E; Fini, N; Moglia, C; Lunetta, C; Marinou, K; Ticozzi, N; Drago Ferrante, G; Scialo, C; Sorarù, G; Trojsi, F; Conte, A; Falzone, Y M; Tortelli, R; Russo, M; Sansone, V A; Mora, G; Silani, V; Volanti, P; Caponnetto, C; Querin, G; Monsurrò, M R; Sabatelli, M; Chiò, A; Riva, N; Logroscino, G; Messina, S; Calvo, A.

In: European Journal of Neurology, Vol. 25, No. 6, 06.2018, p. 861-868.

Research output: Contribution to journalArticle

Mandrioli, J, Ferri, L, Fasano, A, Zucchi, E, Fini, N, Moglia, C, Lunetta, C, Marinou, K, Ticozzi, N, Drago Ferrante, G, Scialo, C, Sorarù, G, Trojsi, F, Conte, A, Falzone, YM, Tortelli, R, Russo, M, Sansone, VA, Mora, G, Silani, V, Volanti, P, Caponnetto, C, Querin, G, Monsurrò, MR, Sabatelli, M, Chiò, A, Riva, N, Logroscino, G, Messina, S & Calvo, A 2018, 'Cardiovascular diseases may play a negative role in the prognosis of amyotrophic lateral sclerosis', European Journal of Neurology, vol. 25, no. 6, pp. 861-868. https://doi.org/10.1111/ene.13620
Mandrioli, J ; Ferri, L ; Fasano, A ; Zucchi, E ; Fini, N ; Moglia, C ; Lunetta, C ; Marinou, K ; Ticozzi, N ; Drago Ferrante, G ; Scialo, C ; Sorarù, G ; Trojsi, F ; Conte, A ; Falzone, Y M ; Tortelli, R ; Russo, M ; Sansone, V A ; Mora, G ; Silani, V ; Volanti, P ; Caponnetto, C ; Querin, G ; Monsurrò, M R ; Sabatelli, M ; Chiò, A ; Riva, N ; Logroscino, G ; Messina, S ; Calvo, A. / Cardiovascular diseases may play a negative role in the prognosis of amyotrophic lateral sclerosis. In: European Journal of Neurology. 2018 ; Vol. 25, No. 6. pp. 861-868.
@article{75b14b43fd2f4b1ca9f375f3c972a4a8,
title = "Cardiovascular diseases may play a negative role in the prognosis of amyotrophic lateral sclerosis",
abstract = "BACKGROUND AND PURPOSE: Only a few studies have considered the role of comorbidities in the prognosis of amyotrophic lateral sclerosis (ALS) and have provided conflicting results.METHODS: Our multicentre, retrospective study included patients diagnosed from 1 January 2009 to 31 December 2013 in 13 referral centres for ALS located in 10 Italian regions. Neurologists at these centres collected a detailed phenotypic profile and follow-up data until death in an electronic database. Comorbidities at diagnosis were recorded by main categories and single medical diagnosis, with the aim of investigating their role in ALS prognosis.RESULTS: A total of 2354 incident cases were collected, with a median survival time from onset to death/tracheostomy of 43 months. According to univariate analysis, together with well-known clinical prognostic factors (age at onset, diagnostic delay, site of onset, phenotype, Revised El Escorial Criteria and body mass index at diagnosis), the presence of dementia, hypertension, heart disease, chronic obstructive pulmonary disease, haematological and psychiatric diseases was associated with worse survival. In multivariate analysis, age at onset, diagnostic delay, phenotypes, body mass index at diagnosis, Revised El Escorial Criteria, dementia, hypertension, heart diseases (atrial fibrillation and heart failure) and haematological diseases (disorders of thrombosis and haemostasis) were independent prognostic factors of survival in ALS.CONCLUSIONS: Our large, multicentre study demonstrated that, together with the known clinical factors that are known to be prognostic for ALS survival, hypertension and heart diseases (i.e. atrial fibrillation and heart failure) as well as haematological diseases are independently associated with a shorter survival. Our findings suggest some mechanisms that are possibly involved in disease progression, giving new interesting clues that may be of value for clinical practice and ALS comorbidity management.",
author = "J Mandrioli and L Ferri and A Fasano and E Zucchi and N Fini and C Moglia and C Lunetta and K Marinou and N Ticozzi and {Drago Ferrante}, G and C Scialo and G Sorar{\`u} and F Trojsi and A Conte and Falzone, {Y M} and R Tortelli and M Russo and Sansone, {V A} and G Mora and V Silani and P Volanti and C Caponnetto and G Querin and Monsurr{\`o}, {M R} and M Sabatelli and A Chi{\`o} and N Riva and G Logroscino and S Messina and A Calvo",
note = "{\circledC} 2018 EAN.",
year = "2018",
month = "6",
doi = "10.1111/ene.13620",
language = "English",
volume = "25",
pages = "861--868",
journal = "European Journal of Neurology",
issn = "1351-5101",
publisher = "Wiley-Blackwell Publishing Ltd",
number = "6",

}

TY - JOUR

T1 - Cardiovascular diseases may play a negative role in the prognosis of amyotrophic lateral sclerosis

AU - Mandrioli, J

AU - Ferri, L

AU - Fasano, A

AU - Zucchi, E

AU - Fini, N

AU - Moglia, C

AU - Lunetta, C

AU - Marinou, K

AU - Ticozzi, N

AU - Drago Ferrante, G

AU - Scialo, C

AU - Sorarù, G

AU - Trojsi, F

AU - Conte, A

AU - Falzone, Y M

AU - Tortelli, R

AU - Russo, M

AU - Sansone, V A

AU - Mora, G

AU - Silani, V

AU - Volanti, P

AU - Caponnetto, C

AU - Querin, G

AU - Monsurrò, M R

AU - Sabatelli, M

AU - Chiò, A

AU - Riva, N

AU - Logroscino, G

AU - Messina, S

AU - Calvo, A

N1 - © 2018 EAN.

PY - 2018/6

Y1 - 2018/6

N2 - BACKGROUND AND PURPOSE: Only a few studies have considered the role of comorbidities in the prognosis of amyotrophic lateral sclerosis (ALS) and have provided conflicting results.METHODS: Our multicentre, retrospective study included patients diagnosed from 1 January 2009 to 31 December 2013 in 13 referral centres for ALS located in 10 Italian regions. Neurologists at these centres collected a detailed phenotypic profile and follow-up data until death in an electronic database. Comorbidities at diagnosis were recorded by main categories and single medical diagnosis, with the aim of investigating their role in ALS prognosis.RESULTS: A total of 2354 incident cases were collected, with a median survival time from onset to death/tracheostomy of 43 months. According to univariate analysis, together with well-known clinical prognostic factors (age at onset, diagnostic delay, site of onset, phenotype, Revised El Escorial Criteria and body mass index at diagnosis), the presence of dementia, hypertension, heart disease, chronic obstructive pulmonary disease, haematological and psychiatric diseases was associated with worse survival. In multivariate analysis, age at onset, diagnostic delay, phenotypes, body mass index at diagnosis, Revised El Escorial Criteria, dementia, hypertension, heart diseases (atrial fibrillation and heart failure) and haematological diseases (disorders of thrombosis and haemostasis) were independent prognostic factors of survival in ALS.CONCLUSIONS: Our large, multicentre study demonstrated that, together with the known clinical factors that are known to be prognostic for ALS survival, hypertension and heart diseases (i.e. atrial fibrillation and heart failure) as well as haematological diseases are independently associated with a shorter survival. Our findings suggest some mechanisms that are possibly involved in disease progression, giving new interesting clues that may be of value for clinical practice and ALS comorbidity management.

AB - BACKGROUND AND PURPOSE: Only a few studies have considered the role of comorbidities in the prognosis of amyotrophic lateral sclerosis (ALS) and have provided conflicting results.METHODS: Our multicentre, retrospective study included patients diagnosed from 1 January 2009 to 31 December 2013 in 13 referral centres for ALS located in 10 Italian regions. Neurologists at these centres collected a detailed phenotypic profile and follow-up data until death in an electronic database. Comorbidities at diagnosis were recorded by main categories and single medical diagnosis, with the aim of investigating their role in ALS prognosis.RESULTS: A total of 2354 incident cases were collected, with a median survival time from onset to death/tracheostomy of 43 months. According to univariate analysis, together with well-known clinical prognostic factors (age at onset, diagnostic delay, site of onset, phenotype, Revised El Escorial Criteria and body mass index at diagnosis), the presence of dementia, hypertension, heart disease, chronic obstructive pulmonary disease, haematological and psychiatric diseases was associated with worse survival. In multivariate analysis, age at onset, diagnostic delay, phenotypes, body mass index at diagnosis, Revised El Escorial Criteria, dementia, hypertension, heart diseases (atrial fibrillation and heart failure) and haematological diseases (disorders of thrombosis and haemostasis) were independent prognostic factors of survival in ALS.CONCLUSIONS: Our large, multicentre study demonstrated that, together with the known clinical factors that are known to be prognostic for ALS survival, hypertension and heart diseases (i.e. atrial fibrillation and heart failure) as well as haematological diseases are independently associated with a shorter survival. Our findings suggest some mechanisms that are possibly involved in disease progression, giving new interesting clues that may be of value for clinical practice and ALS comorbidity management.

U2 - 10.1111/ene.13620

DO - 10.1111/ene.13620

M3 - Article

C2 - 29512869

VL - 25

SP - 861

EP - 868

JO - European Journal of Neurology

JF - European Journal of Neurology

SN - 1351-5101

IS - 6

ER -